|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 94 No. 5 (September 1), 1999:
pp. 1623-1636
Long-Term Ex Vivo Maintenance and Expansion of Transplantable Human
Hematopoietic Stem Cells
Chu-Chih Shih,
Mickey C.-T. Hu,
Jun Hu,
Jeffrey Medeiros, and
Stephen J. Forman
From the Department of Hematology/Bone Marrow Transplantation and the
Department of Anatomic Pathology, City of Hope National Medical Center,
Duarte, CA; the Department of Cell Biology, Amgen Inc, Thousand Oaks,
CA; and the Department of Molecular Biology, Beckman Research Institute
at City of Hope, Duarte, CA.
We have developed a stromal-based in vitro culture system that
facilitates ex vivo expansion of transplantable CD34+
thy-1+ cells using long-term hematopoietic reconstitution
in severe combined immunodeficient-human (SCID-hu) mice as
an in vivo assay for transplantable human hematopoietic stem cells
(HSCs). The addition of leukemia inhibitory factor (LIF) to purified
CD34+ thy-1+ cells on AC6.21 stroma, a
murine bone marrow-derived stromal cell line, caused expansion of
cells with CD34+ thy-1+ phenotype. Addition
of other cytokines, including interleukin-3 (IL-3), IL-6,
granulocyte-macrophage colony-stimulating factor, and stem cell factor,
to LIF in the cultures caused a 150-fold expansion of cells retaining
the CD34+ thy-1+ phenotype. The ex
vivo-expanded CD34+ thy-1+ cells gave rise
to multilineage differentiation, including myeloid, T, and B cells,
when transplanted into SCID-hu mice. Both murine LIF (cannot bind to
human LIF receptor) and human LIF caused expansion of human
CD34+ thy-1+ cells in vitro, suggesting
action through the murine stroma. Furthermore, another human HSC
candidate, CD34+ CD38 cells, shows a
similar pattern of proliferative response. This suggests that
ex vivo expansion of transplantable human stem cells under this
in vitro culture system is a general phenomenon and not just specific
for CD34+ thy-1+ cells.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
A potential role for leukemia inhibitory factor in the increased clonogenicity of human fetal progenitor cells
- Peter Kurre, Stefan Burdach;, Chu-Chih Shih, and Stephen J. Forman
Blood 2000 96: 1199-1200.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
E. Weisberg, R. D. Wright, D. W. McMillin, C. Mitsiades, A. Ray, R. Barrett, S. Adamia, R. Stone, I. Galinsky, A. L. Kung, et al.
Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells
Mol. Cancer Ther.,
May 1, 2008;
7(5):
1121 - 1129.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Giebel, T. Zhang, J. Beckmann, J. Spanholtz, P. Wernet, A. D. Ho, and M. Punzel
Primitive human hematopoietic cells give rise to differentially specified daughter cells upon their initial cell division
Blood,
March 1, 2006;
107(5):
2146 - 2152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Schuringa, K. Y. Chung, G. Morrone, and M. A.S. Moore
Constitutive Activation of STAT5A Promotes Human Hematopoietic Stem Cell Self-Renewal and Erythroid Differentiation
J. Exp. Med.,
September 7, 2004;
200(5):
623 - 635.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Mulloy, J. Cammenga, F. J. Berguido, K. Wu, P. Zhou, R. L. Comenzo, S. Jhanwar, M. A. S. Moore, and S. D. Nimer
Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element
Blood,
December 15, 2003;
102(13):
4369 - 4376.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Giles, A. Keating, A. H. Goldstone, I. Avivi, C. L. Willman, and H. M. Kantarjian
Acute Myeloid Leukemia
Hematology,
January 1, 2002;
2002(1):
73 - 110.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C.-C. Shih, Y. Weng, A. Mamelak, T. LeBon, M. C.-T. Hu, and S. J. Forman
Identification of a candidate human neurohematopoietic stem-cell population
Blood,
October 15, 2001;
98(8):
2412 - 2422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. D. Lewis, G. Almeida-Porada, J. Du, I. R. Lemischka, K. A. Moore, E. D. Zanjani, and C. M. Verfaillie
Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system
Blood,
June 1, 2001;
97(11):
3441 - 3449.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Kurre, S. Burdach;, C.-C. Shih, and S. J. Forman
A potential role for leukemia inhibitory factor in the increased clonogenicity of human fetal progenitor cells
Blood,
August 1, 2000;
96(3):
1199 - 1200.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-C. Shih, M. C.-T. Hu, J. Hu, Y. Weng, P. J. Yazaki, J. Medeiros, and S. J. Forman
A secreted and LIF-mediated stromal cell-derived activity that promotes ex vivo expansion of human hematopoietic stem cells
Blood,
March 15, 2000;
95(6):
1957 - 1966.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|